Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advantage Solutions A | ADV | Dec 26, 2024 | 3.03 | -0.66 |
Advent | AVK | Dec 26, 2024 | 11.87 | -0.67 |
Advent Technologies A | ADN | Dec 26, 2024 | 5.05 | +0.60 |
Adverum Biotechnologies | ADVM | Dec 26, 2024 | 5.02 | +5.91 |
AdvisorShares Pure US Cannabis ETF | MSOS | Dec 26, 2024 | 3.65 | -0.82 |
Advisorshares Star Global Buy-Write ETF | VEGA | Dec 26, 2024 | 44.07 | +0.77 |
AECOM | ACM | Dec 26, 2024 | 108.59 | +0.17 |
Aegon N.V ADR | AEG | Dec 26, 2024 | 5.87 | +0.51 |
Aehr Test Systems | AEHR | Dec 26, 2024 | 16.29 | +7.67 |
Aemetis | AMTX | Dec 26, 2024 | 2.86 | +8.75 |
Aeon Biopharma | AEON | Dec 26, 2024 | 0.60 | +3.11 |
AerCap Holdings | AER | Dec 26, 2024 | 95.47 | -0.21 |
Aeries Technology | AERT | Dec 26, 2024 | 0.87 | -0.55 |
Aerospace & Defense Powershares | PPA | Dec 26, 2024 | 117.27 | +0.35 |
Aerovate Therapeutics | AVTE | Dec 26, 2024 | 2.63 | +1.15 |
AeroVironment | AVAV | Dec 26, 2024 | 161.50 | +0.86 |
AerSale | ASLE | Dec 26, 2024 | 6.19 | -1.75 |
AES | AES | Dec 26, 2024 | 12.84 | -1.38 |
Aetherium Acquisition A | GMFI | Dec 26, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Dec 26, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Dec 26, 2024 | 0.59 | +3.17 |
Aeva Technologies | AEVA | Dec 26, 2024 | 4.78 | +6.46 |
AEye A | LIDR | Dec 26, 2024 | 1.28 | +13.27 |
Affiliated Managers Group | AMG | Dec 26, 2024 | 189.47 | +1.06 |
Affimed N.V. | AFMD | Dec 26, 2024 | 1.27 | +2.42 |
Affinity Bancshares | AFBI | Dec 26, 2024 | 21.81 | -0.23 |
Affirm A | AFRM | Dec 26, 2024 | 66.85 | +1.44 |
Aflac | AFL | Dec 26, 2024 | 103.66 | +0.41 |
Africa Index ETF Market Vectors | AFK | Dec 26, 2024 | 15.73 | +0.32 |
Afya A | AFYA | Dec 26, 2024 | 15.91 | +2.18 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.